Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 10, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 10, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 20, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 19, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 19, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 10, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Aug 10, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 12, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 10, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 10, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Feb 10, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 10, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 10, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 10, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 10, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 12, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 10, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 10, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 10, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 10, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 14, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 14, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 25, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 10, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 9, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 9, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 9, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 20, 2019 | EPEN | O | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | Loading... |
| Jun 20, 2019 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Jun 20, 2019 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Jun 20, 2019 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Jun 12, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 20, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 6, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 016
Printed materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders
Class 035
Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
Class 041
Healthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
Class 044
Providing a website featuring information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders
Additional Information
Pseudo Mark
INTRAVENOUS IMMUNOGLOBULIN IS OUR MIDDLE NAME
Classification
International Classes
016
035
041
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IVIG"